VahatiCor

About VahatiCor

VahatiCor, Inc., a member of the T45 Labs portfolio, is committed to advancing medical technology by creating innovative solutions for unmet clinical needs, particularly in cardiac care. Their mission is to transform patients' lives worldwide through patient-centric innovation, focusing on effective treatments for coronary microvascular dysfunction to relieve symptoms and improve well-being.

Products & Services

A-FLUX Reducer System®:A minimally-invasive interventional therapy designed to relieve symptoms of coronary microvascular dysfunction. It features SwiftCell® Technology for rapid response, reliable delivery, and effective symptom relief by redistributing oxygen supply.

SwiftCell® Technology:A technology integrated into the A-FLUX Reducer System, featuring a variable cell structure, hourglass shape, and shape-memory material to facilitate swift, targeted therapy and conform to the coronary sinus for proper placement and retention.

Specialties

Coronary Microvascular Dysfunction Treatment Interventional Cardiology Medical Device Innovation

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B T: - FT: Series B	A: 23000000 MR: - FA: $23 million FAN: 23000000	D: 2025-11-18 FD: 2025-11-18	3 investors

Series B Latest

2025-11-18

$23.0M

3 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Marwan Berrada

FOUNDER AND CHAIRMAN

K

Kevin Van Bladel

CTO

M

Michael Mandel

Head of Corporate Development

M

Mark Niggli

CCO

J

Janie Mandrusov

VP, Clinical Affairs

A

Angela Mallery

VP of Regulatory and Quality Affairs

View 3 more team members with Pro

Unlock Full Team Directory

Recent News

VahatiCor Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised